| Dr Molly Larson-wakeman, PHARMD | |
|
2920 N 4th St, Flagstaff, AZ 86004-1816 | |
| (928) 522-9400 | |
| Not Available |
| Full Name | Dr Molly Larson-wakeman |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Ambulatory Care |
| Location | 2920 N 4th St, Flagstaff, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174181812 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P2201X | Pharmacist - Ambulatory Care | S023430 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Molly Larson-wakeman, PHARMD 5901 Leupp Rd, Flagstaff, AZ 86004-8531 Ph: (707) 834-5254 | Dr Molly Larson-wakeman, PHARMD 2920 N 4th St, Flagstaff, AZ 86004-1816 Ph: (928) 522-9400 |
News Archive
Cancer is caused by an accumulation of genetic changes in a cell, that overcome the normal checks and balances leading to uncontrolled growth. A complex, interacting network of proteins controls all of a cell's processes, from metabolism to growth and division.
Seizures that occur in the first few weeks of life are a major predictor of future adverse neurological outcomes. Currently approved antiepileptic drugs (AEDs) are effective in stopping seizures in less than 50% of these neonatal cases. The approved therapies can also have undesirable side effects.
Regenerative medicine company Orthocell Limited is pleased to announce receipt of European regulatory approval (CE Mark) for its CelGro collagen medical device.
A research team including NIBIB-funded scientists has developed an improved MRI technique with the potential to provide more precise and effective treatment for prostate cancer. The imaging technique improves upon standard MRI to obtain clearer images of the extent of the tumor and its exact location. A sharper image can provide more accurate biopsies, enable better treatment planning, and help surgeons pinpoint the tumor while sparing surrounding healthy tissue.
The drug topotecan does not increase survival for ovarian cancer patients when used with standard chemotherapy in first-line treatment and is not recommended for future use.
› Verified 9 days ago
Dr. Whitney Farnsworth Morejon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 S Plaza Way, Flagstaff, AZ 86001 Phone: 928-556-9170 | |
Teresa Jesus Aleman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2920 N 4th St, Flagstaff, AZ 86004 Phone: 928-522-9403 | |
Dr. Cody Ray Plaisted, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3480 E Route 66, Flagstaff, AZ 86004 Phone: 307-399-5957 | |
Nathaniel Green, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1025 S Milton Rd, Flagstaff, AZ 86001 Phone: 928-779-9588 | |
Dr. Kari Wilson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4910 N Us Highway 89, Safeway Pharmacy Dept, Flagstaff, AZ 86004 Phone: 928-526-5686 Fax: 928-526-4710 | |
Melissa C Kelly, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2610 E Route 66, Flagstaff, AZ 86004 Phone: 928-773-1155 | |
Christine Long, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2601 E Huntington Dr, Flagstaff, AZ 86004 Phone: 928-774-3409 |